Verition Fund Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$506K Hold
46,687
– – ﹤0.01% 1618
2026
Q2
$499K Sell
46,687
-122,416
-72% -$1.31M ﹤0.01% 1636
2026
Q1
$1.79M Sell
169,103
-22,432
-12% -$236K 0.01% 1081
2025
Q4
$2.01M Sell
191,535
-10,003
-5% -$104K 0.01% 1616
2025
Q3
$2.09M Hold
201,538
– – 0.01% 1938
2025
Q2
$2.08M Sell
201,538
-15,002
-7% -$152K 0.01% 1911
2025
Q1
$2.18M Buy
+216,540
New +$2.18M 0.01% 1510

Other funds holding TDAC

Verition Fund Management's TDAC Position: Q3 2026 in Review

Verition Fund Management held its Translational Development Acquisition Corp (TDAC) position steady in Q3 2026 at 46,687 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Verition Fund Management first reported a position in TDAC in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.18M in Q1 2025. 37 funds tracked by Wall St. Rank hold TDAC as of Q3 2026.

  • Verition Fund Management held 46,687 shares of Translational Development Acquisition Corp worth $506K as of Q3 2026.
  • Verition Fund Management left its Translational Development Acquisition Corp share count unchanged in Q3 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of Verition Fund Management's portfolio in Q3 2026, its #1618 holding.
  • Verition Fund Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 7 quarters since.
  • Verition Fund Management's Translational Development Acquisition Corp position peaked at $2.18M in Q1 2025.
  • 37 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.